# Transcutaneous Pulsed Radiofrequency for the Treatment of Diabetic Peripheral Neuropathy Pain

> **NCT07725419** · NA · COMPLETED · sponsor: **Algiamed Technologies USA, Inc.** · enrollment: 92 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain (DPN)
- Diabetic Peripheral Neuropathy
- Diabetic Peripheral Neuropathic Pain

## Interventions

- **DEVICE:** NMS 460 Pulsed Radio Frequency Device
- **DEVICE:** Placebo Device

## Key facts

- **NCT ID:** NCT07725419
- **Lead sponsor:** Algiamed Technologies USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725419, "Transcutaneous Pulsed Radiofrequency for the Treatment of Diabetic Peripheral Neuropathy Pain". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07725419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*